<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729011</url>
  </required_header>
  <id_info>
    <org_study_id>18</org_study_id>
    <nct_id>NCT03729011</nct_id>
  </id_info>
  <brief_title>Delirium Reduction by Volatile Anesthesia in Cardiac Surgery</brief_title>
  <acronym>DELICATE</acronym>
  <official_title>Delirium Reduction by Volatile Anesthesia in Cardiac Surgery: Prospective, Randomized, Single-blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parallel group, prospective, randomized, controlled, single-blinded trial. The aim of our
      study is to test the hypothesis that volatile anesthesia would reduce the incidence of early
      postoperative delirium in patients undergoing cardiac surgery with CPB as compared to TIVA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Delirium is a common neurologic complication after cardiac surgery. Up to 52% of
      postoperative cardiac surgery patients have delirium. The occurrence of postoperative
      delirium is associated with worse outcomes, including prolonged length of stay in the ICU and
      hospital, increased morbidity and mortality, compromised long-term cognitive function and
      physical ability, and elevated medical care costs. Morbidity of postoperative cognitive
      dysfunction and delirium mostly common in patients with age more than 60 years.

      Several factors including cerebral anoxia, embolism, excessive excitatory neurotransmitter
      release, systemic inflammatory response, electrolyte and metabolic disorders and hemodynamic
      changes have been demonstrated to contribute to postoperative neurological dysfunction and
      delirium.

      Previous studies have shown that inhalation anaesthesia and total intravenous anaesthesia
      (TIVA) may produce different degrees of cerebral protection in these patients. Effects of
      this two types of anaesthesia in cardiac surgery with CPB remain controversial and much
      debated.

      Inhalation agents depress glucose metabolism, decrease cerebral metabolic rate and oxygen
      consumption. They also partially uncouple the reactivity of cerebral blood flow to CO2. The
      changes in cerebral blood flow (CBF) depend on the changes in cerebral metabolism and on
      direct vasodilatory effects. Cerebral autoregulation is dose-dependently altered. Volatile
      anaesthetics have been shown to initiate early ischemic preconditioning in neurons, but
      models of focal brain ischemia suggest it can take 24 h for preconditioning to develop fully.

      Propofol is a well-known potentiator of GABAA receptors, it reduces cerebrovascular
      resistance, CBF and cerebral oxygen delivery during cardiopulmonary bypass. A neuroprotective
      effect of propofol has been shown to be present in many in vitro and in vivo established
      experimental models of mild/moderate acute cerebral ischemia.

      In recent meta-analysis of 13 randomized controlled studies Chen et al compared the
      neuroprotective effects of inhalational anesthesia and those of total intravenous anesthesia
      (TIVA) in cardiac surgery with cardiopulmonary bypass. They have shown that anesthesia with
      volatile agents appeared to provide better cerebral protection than TIVA. As this
      meta-analysis had several limitations (small sample size of included studies, high
      heterogenity, etc.), further studies with larger clinically relevant sample-sizes are needed
      to demonstrate which anesthetics are more beneficial in terms of brain protection in cardiac
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2019</start_date>
  <completion_date type="Anticipated">January 29, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 29, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomly allocated to receive either inhalation anaesthesia or TIVA. Permuted-block randomization will be used to allocate subjects to one of the study groups. Sequentially numbered sealed opaque envelopes will contain the treatment code, to be opened in the morning of surgery. Patients will be unaware of group assignment. All the statistical analyses will be performed by the biostatistician not involved in treatment allocation.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>5 days after surgery</time_frame>
    <description>Postoperative delirium detection will be managed with Confusion Assessment Method for the ICU (CAM-ICU)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early postoperative cognitive dysfunction</measure>
    <time_frame>7 days after surgery</time_frame>
    <description>We will use Montreal Cognitive Assessment (MoCA) to detect cognitive dysfunction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium duration</measure>
    <time_frame>10 days after surgery</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>30 days</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>60 days</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day all-cause mortality</measure>
    <time_frame>30 days</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One-year all-cause mortality</measure>
    <time_frame>1 year</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction (MI)</measure>
    <time_frame>30 days</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Stroke will be diagnosed by neurologist (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seizures</measure>
    <time_frame>30 days</time_frame>
    <description>Presence of Seizures (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of acute kidney injury (AKI)</measure>
    <time_frame>30 days</time_frame>
    <description>According to KDIGO criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapy</measure>
    <time_frame>30 days</time_frame>
    <description>We will collect data about need of renal replacement therapy (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>30 days</time_frame>
    <description>We will collect data about infectious complications: wound infection, mediastinitis, pneumonia, positive blood culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment with Behavioral Pain Scale (BPS)</measure>
    <time_frame>5 days after surgery</time_frame>
    <description>The BPS is an observational pain scale. It has been validated for use in deeply sedated, mechanically ventilated patients. The BPS contains 3 subscales: facial expression, upper limb movements, and compliance with mechanical ventilation. Each subscale is scored from 1 (no response) to 4 (full response). Therefore, BPS scores range from 3 (no pain) to 12 (maximal pain). A BPS score of 6 or higher is considered to reflect unacceptable pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment with Numerical Rating Scale (NRS)</measure>
    <time_frame>5 days after surgery</time_frame>
    <description>A NRS involves asking the patient to rate his or her pain from 0 to 10 (11 point scale) or from 0 to 100 (101 point scale) with the understanding that 0 is equal to no pain and 10 or 100 is equal to worst possible pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">672</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Volatile anesthesia group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TIVA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Volatile agent</intervention_name>
    <description>Patients will receive volatile agent to provide general anaesthesia, including CPB period. Volatile agents will be administered from anesthesia induction to the end of surgery. Concentration (MAC) of volatile agent will be selected by anaesthesiologist according to clinical situation and patient features.</description>
    <arm_group_label>Volatile anesthesia group</arm_group_label>
    <other_name>Sevoflurane</other_name>
    <other_name>Desflurane</other_name>
    <other_name>Isoflurane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Patients will receive propofol and no volatile agent. Propofol will be used for induction and maintenance of anesthesia.</description>
    <arm_group_label>TIVA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females &gt; 65 years

          -  Written informed consent

          -  Cardiac surgery with CPB

        Exclusion Criteria:

          -  Emergency surgery

          -  Surgery on aorta

          -  Known allergy to components of anaesthesia

          -  Pregnancy

          -  Hemodynamically significant stenosis of carotid arteries

          -  Parkinson's disease

          -  Liver cirrhosis (Child B or C)

          -  Current enrollment into another RCT (in the last 30 days)

          -  Previous enrollment and randomization into the DELICATE trial

          -  Poor language comprehension

          -  Preoperative Medications: Anticholinergics (dimedrol, atropine, dramina),
             antidepressants, antiepileptics, antiparkinson drugs, chemotherapeutic agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vladimir Lomivorotov, PHD</last_name>
    <phone>347 60 54</phone>
    <phone_ext>383</phone_ext>
    <email>vvlom@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gleb Moroz, PHD</last_name>
    <phone>347 60 54</phone>
    <phone_ext>383</phone_ext>
    <email>Glebmorozz@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI)</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valery Lichvancev</last_name>
      <email>lik0704@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Galina Titova</last_name>
      <email>galinatitova@mail.ru</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Meshalkin Research Institute of Pathology of Circulation</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Lomivorotov</last_name>
      <phone>3833476058</phone>
      <email>v.lomivorotov@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State University Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergey Efremov, PHD</last_name>
      <email>efremovsergm@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tomsk National Research Medical Center of the Russian Academy of Sciences</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolay Kamenshikov</last_name>
      <email>nikolajkamenof@mail.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <reference>
    <citation>Brown CH. Delirium in the cardiac surgical ICU. Curr Opin Anaesthesiol. 2014 Apr;27(2):117-22. doi: 10.1097/ACO.0000000000000061. Review.</citation>
    <PMID>24514034</PMID>
  </reference>
  <reference>
    <citation>Martin BJ, Buth KJ, Arora RC, Baskett RJ. Delirium: a cause for concern beyond the immediate postoperative period. Ann Thorac Surg. 2012 Apr;93(4):1114-20. doi: 10.1016/j.athoracsur.2011.09.011. Epub 2011 Dec 24.</citation>
    <PMID>22200370</PMID>
  </reference>
  <reference>
    <citation>Gottesman RF, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, Selnes OA, McKhann GM. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol. 2010 Mar;67(3):338-44. doi: 10.1002/ana.21899.</citation>
    <PMID>20373345</PMID>
  </reference>
  <reference>
    <citation>Rudolph JL, Inouye SK, Jones RN, Yang FM, Fong TG, Levkoff SE, Marcantonio ER. Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc. 2010 Apr;58(4):643-9. doi: 10.1111/j.1532-5415.2010.02762.x. Epub 2010 Mar 22.</citation>
    <PMID>20345866</PMID>
  </reference>
  <reference>
    <citation>Franco K, Litaker D, Locala J, Bronson D. The cost of delirium in the surgical patient. Psychosomatics. 2001 Jan-Feb;42(1):68-73.</citation>
    <PMID>11161124</PMID>
  </reference>
  <reference>
    <citation>Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7. doi: 10.1164/rccm.200904-0537OC. Epub 2009 Sep 10.</citation>
    <PMID>19745202</PMID>
  </reference>
  <reference>
    <citation>Bickel H, Gradinger R, Kochs E, Förstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord. 2008;26(1):26-31. doi: 10.1159/000140804. Epub 2008 Jun 24.</citation>
    <PMID>18577850</PMID>
  </reference>
  <reference>
    <citation>Li YW, Li HJ, Li HJ, Feng Y, Yu Y, Guo XY, Li Y, Zhao BJ, Hu XY, Zuo MZ, Zhang HY, Wang MR, Ji P, Yan XY, Wu YF, Wang DX. Effects of two different anesthesia-analgesia methods on incidence of postoperative delirium in elderly patients undergoing major thoracic and abdominal surgery: study rationale and protocol for a multicenter randomized controlled trial. BMC Anesthesiol. 2015 Oct 13;15:144. doi: 10.1186/s12871-015-0118-5.</citation>
    <PMID>26459347</PMID>
  </reference>
  <reference>
    <citation>Nguyen Q, Uminski K, Hiebert BM, Tangri N, Arora RC. Midterm outcomes after postoperative delirium on cognition and mood in patients after cardiac surgery. J Thorac Cardiovasc Surg. 2018 Feb;155(2):660-667.e2. doi: 10.1016/j.jtcvs.2017.09.131. Epub 2017 Oct 20.</citation>
    <PMID>29132782</PMID>
  </reference>
  <reference>
    <citation>Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol. 2010 Jun;119(6):737-54. doi: 10.1007/s00401-010-0674-1. Epub 2010 Mar 24. Review.</citation>
    <PMID>20309566</PMID>
  </reference>
  <reference>
    <citation>Caplan JP, Chang G. Refeeding syndrome as an iatrogenic cause of delirium: a retrospective pilot study. Psychosomatics. 2010 Sep-Oct;51(5):419-24. doi: 10.1176/appi.psy.51.5.419.</citation>
    <PMID>20833941</PMID>
  </reference>
  <reference>
    <citation>Siepe M, Pfeiffer T, Gieringer A, Zemann S, Benk C, Schlensak C, Beyersdorf F. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011 Jul;40(1):200-7. doi: 10.1016/j.ejcts.2010.11.024. Epub 2010 Dec 18.</citation>
    <PMID>21168339</PMID>
  </reference>
  <reference>
    <citation>Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):764-72. Review.</citation>
    <PMID>18693233</PMID>
  </reference>
  <reference>
    <citation>Wimmer-Greinecker G, Matheis G, Brieden M, Dietrich M, Oremek G, Westphal K, Winkelmann BR, Moritz A. Neuropsychological changes after cardiopulmonary bypass for coronary artery bypass grafting. Thorac Cardiovasc Surg. 1998 Aug;46(4):207-12.</citation>
    <PMID>9776494</PMID>
  </reference>
  <reference>
    <citation>Chen F, Duan G, Wu Z, Zuo Z, Li H. Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis. BMJ Open. 2017 Oct 11;7(10):e014629. doi: 10.1136/bmjopen-2016-014629. Review.</citation>
    <PMID>29025825</PMID>
  </reference>
  <reference>
    <citation>Morimoto Y, Yoshimura M, Utada K, Setoyama K, Matsumoto M, Sakabe T. Prediction of postoperative delirium after abdominal surgery in the elderly. J Anesth. 2009;23(1):51-6. doi: 10.1007/s00540-008-0688-1. Epub 2009 Feb 22.</citation>
    <PMID>19234823</PMID>
  </reference>
  <reference>
    <citation>Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D, Chang J. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem. 1999 Dec;73(6):2524-30.</citation>
    <PMID>10582614</PMID>
  </reference>
  <reference>
    <citation>Wang H, Lu S, Yu Q, Liang W, Gao H, Li P, Gan Y, Chen J, Gao Y. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci (Elite Ed). 2011 Jan 1;3:604-15.</citation>
    <PMID>21196338</PMID>
  </reference>
  <reference>
    <citation>McAuliffe JJ, Loepke AW, Miles L, Joseph B, Hughes E, Vorhees CV. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology. 2009 Sep;111(3):533-46. doi: 10.1097/ALN.0b013e3181b060d3.</citation>
    <PMID>19672176</PMID>
  </reference>
  <reference>
    <citation>Bilotta F, Stazi E, Zlotnik A, Gruenbaum SE, Rosa G. Neuroprotective effects of intravenous anesthetics: a new critical perspective. Curr Pharm Des. 2014;20(34):5469-75. Review.</citation>
    <PMID>24669972</PMID>
  </reference>
  <reference>
    <citation>Young Y, Menon DK, Tisavipat N, Matta BF, Jones JG. Propofol neuroprotection in a rat model of ischaemia reperfusion injury. Eur J Anaesthesiol. 1997 May;14(3):320-6.</citation>
    <PMID>9202922</PMID>
  </reference>
  <reference>
    <citation>Ergün R, Akdemir G, Sen S, Taşçi A, Ergüngör F. Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurg Rev. 2002 Mar;25(1-2):95-8.</citation>
    <PMID>11954772</PMID>
  </reference>
  <reference>
    <citation>Van Aken H, Van Hemelrijck J. Influence of anesthesia on cerebral blood flow and cerebral metabolism: an overview. Agressologie. 1991;32(6-7):303-6.</citation>
    <PMID>1843831</PMID>
  </reference>
  <reference>
    <citation>Lingehall HC, Smulter NS, Lindahl E, Lindkvist M, Engström KG, Gustafson YG, Olofsson B. Preoperative Cognitive Performance and Postoperative Delirium Are Independently Associated With Future Dementia in Older People Who Have Undergone Cardiac Surgery: A Longitudinal Cohort Study. Crit Care Med. 2017 Aug;45(8):1295-1303. doi: 10.1097/CCM.0000000000002483.</citation>
    <PMID>28481752</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 3, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Cognitive dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

